RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric siteKatarzyna Z. Haza(University of Leeds), Darren C. Tomlinson(St James's University Hospital)Nature CommunicationsJune 30, 202110.1038/s41467-021-24316-0Cited by 43SaveCiteExport RISWatch citationsRelated PapersFGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms|PLoS ONE|2012|92Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles|iScience|2024|3Targeting Grb2 SH3 Domains with Affimer Proteins Provides Novel Insights into Ras Signalling Modulation|Biomolecules|2024|3